| Not Yet Recruiting | Gut Microbiome in Gynecological Cancer Patients With Pelvic Toxicity: Controls Versus Ozone Treatment. (MicrOz Pelvic Toxicity, Radiation Toxicity, Chemotherapy Toxicity | — | 2026-01-15 |
| Not Yet Recruiting | Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2026 and 2029. Chemotherapy-Induced Peripheral Neuropathy, Radiation Toxicity, Chronic Pain | — | 2026-01-14 |
| Recruiting | Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pa Chronic Pelvic Pain Syndrome (CPPS), Radiation-Induced Disorder, Radiotherapy Side Effects | — | 2025-02-10 |
| Recruiting | Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia, Numbness | Phase 2 / Phase 3 | 2025-02-07 |
| Recruiting | Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544). Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia, Numbness | Phase 2 / Phase 3 | 2025-02-07 |
| Recruiting | Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025 Radiation Toxicity, Chemotherapeutic Toxicity, Chemotherapy-induced Peripheral Neuropathy | — | 2022-06-15 |
| Recruiting | Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ) Chemotherapy-induced Peripheral Neuropathy, Pain, Neuropathic, Pain Syndrome | Phase 2 / Phase 3 | 2020-11-30 |
| Terminated | Ozone Therapy in Refractory Ischemic Heart Disease. Ischemic Heart Disease | Phase 2 / Phase 3 | 2020-02-26 |
| Active Not Recruiting | Ozone Therapy in Patients on Waiting List for Surgery Due to Disc Herniation: Prospective, Post-authorization Lumbar Herniated Disc | — | 2018-03-09 |
| Terminated | FMISO-PET in Brain Tumors and SCS Effect Malignant Glioma | Phase 2 | 2013-06-01 |